Exchange Announcement • 28 Nov 2024 05:30
Exchange Announcement • 07 Nov 2024 22:05
Exchange Announcement • 07 Nov 2024 22:00
Exchange Announcement • 07 Oct 2024 20:10
Exchange Announcement • 28 Sep 2024 04:01
ENTITY
Imunon (IMNN US)
Imunon (IMNN US)
5
Analysis
Health Care • United States
IMUNON, Inc. operates as a clinical stage biotechnology company. The Company focuses on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON serves customers worldwide.
more
x